Related Experiment Video
Updated: Dec 10, 2025

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
Transformation of CMML to AML presenting with acute kidney injury
Rebecca DeBoer1, Ian Garrahy1, Andrew Rettew1
1Department of Medicine, Reading Hospital, Reading, PA, USA.
Abstract:
Characterized by bone marrow dysplasia and peripheral blood monocytosis, chronic myelomonocytic leukemia (CMML) is one of the most aggressive chronic leukemias and has a propensity for progression to acute myeloid leukemia (AML). Patients with newly diagnosed AML generally present with symptoms related to complications of pancytopenia but can also present with renal insufficiency. We present a 79-year-old male with a past medical history of CMML and chronic kidney disease stage 3 (baseline creatinine 1.8 mg/dL) who presented with one day of inability to urinate and 20-lb unintentional weight loss, fatigue, and bone pain over 3 months. Laboratory evaluation revealed leukocytosis of 88.5 x 103/uL (normal 4.8-10.8 x 103/uL) with 24.0% monocytes on differential, creatinine 2.94 mg/dL (baseline creatinine 1.7-1.9 mg/dL), uric acid 19.8 mg/dL, potassium 4.0 mmol/L, phosphorus 4.0 mg/dL, calcium 9.2 mg/dL, and albumin 3.2 g/dL. Urinalysis was significant for protein 200 mg/dL, 20/LPF granular casts, and 7/LPF hyaline casts. Bone marrow biopsy revealed 20-30% blasts with monocytic features of differentiation consistent with acute myeloid leukemia. Computed tomography (CT) of the abdomen and pelvis appreciated splenomegaly with retroperitoneal, and pelvic lymphadenopathy. Kidney failure can complicate the presentation of AML but can be rapidly reversible with treatment. In patients with CMML who have progressive renal insufficiency and hyperuricemia, there should be a high index of suspicion for progression to AML.
Insights
Chronic myelomonocytic leukemia (CMML) can progress to acute myeloid leukemia (AML). Progressive renal insufficiency and hyperuricemia in CMML patients suggest AML transformation, which may be reversible with treatment.
Area of Science:
- Hematology
- Oncology
- Nephrology
Background:
- Chronic myelomonocytic leukemia (CMML) is an aggressive myeloid neoplasm characterized by bone marrow dysplasia and peripheral blood monocytosis.
- CMML has a significant risk of transforming into acute myeloid leukemia (AML), a more aggressive hematologic malignancy.
- Acute myeloid leukemia (AML) often presents with complications of pancytopenia or renal insufficiency.
Observation:
- A 79-year-old male with a history of CMML and stage 3 chronic kidney disease presented with acute anuria, unintentional weight loss, fatigue, and bone pain.
- Laboratory findings included marked leukocytosis with monocytosis, elevated creatinine, hyperuricemia, and hypoalbuminemia.
- Bone marrow biopsy confirmed acute myeloid leukemia with monocytic differentiation, and imaging revealed splenomegaly and lymphadenopathy.
Findings:
- The patient's presentation of acute kidney injury, hyperuricemia, and bone pain in the context of CMML was indicative of progression to acute myeloid leukemia.
- The bone marrow biopsy confirmed AML with monocytic features, supporting the clinical suspicion.
- Imaging studies identified extramedullary disease, including splenomegaly and lymphadenopathy.
Implications:
- Progressive renal insufficiency and hyperuricemia in CMML patients warrant a high index of suspicion for AML transformation.
- Early recognition and treatment of AML in CMML patients can lead to potentially reversible kidney failure.
- This case highlights the importance of monitoring renal function and uric acid levels in CMML patients to detect disease progression.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis I: Introduction

